Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengling Li

Showing results (211-220 of 253) with videos related to

Pageof 26
Sort By:
The Biochemical Journal|September 20, 2012
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5Guillermo Senisterra, Hong Wu, Abdellah Allali-Hassani, et al.
Journal of Medicinal Chemistry|August 16, 2019
Selective, Small-Molecule Co-Factor Binding Site Inhibition of a Su(var)3-9, Enhancer of Zeste, Trithorax Domain Containing Lysine MethyltransferaseAlexandria P Taylor, Magdalena Swewczyk, Steven Kennedy, et al.
Journal of Medicinal Chemistry|April 15, 2016
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2Erik Eggert, Roman C Hillig, Silke Koehr, et al.
Nature Communications|July 18, 2018
Act1 is a negative regulator in T and B cells via direct inhibition of STAT3Cun-Jin Zhang, Chenhui Wang, Meiling Jiang, et al.
ACS Chemical Biology|April 26, 2013
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1Kyle D Konze, Anqi Ma, Fengling Li, et al.
ACS Infectious Diseases|September 20, 2023
Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric InhibitorsNicole L Inniss, Ján Kozic, Fengling Li, et al.
Oncotarget|May 3, 2018
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myelomaKazuhide Nakayama, Magdalena M Szewczyk, Carlo Dela Sena, et al.
Journal of Medicinal Chemistry|June 9, 2023
Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-MethyltransferaseIsha Singh, Fengling Li, Elissa A Fink, et al.
Nature Communications|January 4, 2019
A chemical biology toolbox to study protein methyltransferases and epigenetic signalingSebastian Scheer, Suzanne Ackloo, Tiago S Medina, et al.
The Journal of Biological Chemistry|April 1, 2015
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2Hannah Nguyen, Abdellah Allali-Hassani, Stephen Antonysamy, et al.
Pageof 26

Showing results (211-220 of 253) with videos related to

Sort By:
Pageof 26
The Biochemical Journal|September 20, 2012
Small-molecule inhibition of MLL activity by disruption of its interaction with WDR5Guillermo Senisterra, Hong Wu, Abdellah Allali-Hassani, et al.
Journal of Medicinal Chemistry|August 16, 2019
Selective, Small-Molecule Co-Factor Binding Site Inhibition of a Su(var)3-9, Enhancer of Zeste, Trithorax Domain Containing Lysine MethyltransferaseAlexandria P Taylor, Magdalena Swewczyk, Steven Kennedy, et al.
Journal of Medicinal Chemistry|April 15, 2016
Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2Erik Eggert, Roman C Hillig, Silke Koehr, et al.
Nature Communications|July 18, 2018
Act1 is a negative regulator in T and B cells via direct inhibition of STAT3Cun-Jin Zhang, Chenhui Wang, Meiling Jiang, et al.
ACS Chemical Biology|April 26, 2013
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1Kyle D Konze, Anqi Ma, Fengling Li, et al.
ACS Infectious Diseases|September 20, 2023
Discovery of a Druggable, Cryptic Pocket in SARS-CoV-2 nsp16 Using Allosteric InhibitorsNicole L Inniss, Ján Kozic, Fengling Li, et al.
Oncotarget|May 3, 2018
TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myelomaKazuhide Nakayama, Magdalena M Szewczyk, Carlo Dela Sena, et al.
Journal of Medicinal Chemistry|June 9, 2023
Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-MethyltransferaseIsha Singh, Fengling Li, Elissa A Fink, et al.
Nature Communications|January 4, 2019
A chemical biology toolbox to study protein methyltransferases and epigenetic signalingSebastian Scheer, Suzanne Ackloo, Tiago S Medina, et al.
The Journal of Biological Chemistry|April 1, 2015
LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2Hannah Nguyen, Abdellah Allali-Hassani, Stephen Antonysamy, et al.
Pageof 26